JM

John D. Mendlein

FT Fate Therapeutics: 2 patents #4 of 17Top 25%
AP Atyr Pharma: 1 patents #7 of 14Top 50%
BS Bristol-Myers Squibb: 1 patents #182 of 545Top 35%
Overall (2021): #47,106 of 548,734Top 9%
4
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11149077 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR Ray Camphausen, David Fabrizio, Martin C. Wright, Patrick Gage 2021-10-19
11072787 Histidyl-tRNA synthetase-Fc conjugates Chi-Fang Wu, Darin Lee, Jeffry D. Watkins, Kristi Helen Piehl, Kyle P. Chiang +3 more 2021-07-27
11052118 Enhanced stem cell composition Daniel Shoemaker, David Robbins, Caroline Desponts 2021-07-06
10980838 Methods of treating ischemia Dan Shoemaker, Pratik S. Multani, David Robbins 2021-04-20